Vactosertib is a small-molecule compound under investigation for its role as a TGF-beta type I receptor kinase inhibitor, with potential applications in research on fibrotic and neoplastic diseases. It is currently being studied in clinical trials for use in combination with other therapies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1352608-82-2
Gadoxetate Disodium
gadolinium-based MRI contrast agent
Clarithromycin lactobionate
macrolide antibiotic active pharmaceutical ingredient
Albendazole-(methyl-d3)
active pharmaceutical ingredient
Pibrentasvir
antiviral active pharmaceutical ingredient
2-fluoro-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline
FJCDSQATIJKQKA-UHFFFAOYSA-N
CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4